Elizabeth A. Czerepak
2018
In 2018, Elizabeth A. Czerepak earned a total compensation of $132K as Former Chief Financial Officer at PharmAthene, a 75% decrease compared to previous year.
Compensation breakdown
| Salary | $126,923 |
|---|---|
| Other | $5,076 |
| Total | $131,999 |
Czerepak received $126.9K in salary, accounting for 96% of the total pay in 2018.
Czerepak also received $5.1K in other compensation.
Rankings
In 2018, Elizabeth A. Czerepak's compensation ranked 13,959th out of 14,244 executives tracked by ExecPay. In other words, Czerepak earned more than 2.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,959 out of 14,244 | 2nd |
Division Manufacturing | 5,653 out of 5,765 | 2nd |
Major group Chemicals And Allied Products | 2,095 out of 2,128 | 2nd |
Industry group Drugs | 1,786 out of 1,817 | 2nd |
Industry Pharmaceutical Preparations | 1,367 out of 1,391 | 2nd |
Source: SEC filing on August 22, 2019.
Czerepak's colleagues
We found four more compensation records of executives who worked with Elizabeth A. Czerepak at PharmAthene in 2018.